227 related articles for article (PubMed ID: 17827739)
21. Intensified regression of colon cancer liver metastases in mice treated with irinotecan and the immunomodulator JBT 3002.
Shinohara H; Bucana CD; Killion JJ; Fidler IJ
J Immunother; 2000; 23(3):321-31. PubMed ID: 10838661
[TBL] [Abstract][Full Text] [Related]
22. Imaging Nuclear-Cytoplasmic Dynamics in Primary and Metastatic Colon Cancer in Nude Mice.
Hasegawa K; Suetsugu A; Nakamura M; Matsumoto T; Aoki H; Kunisada T; Bouvet M; Shimizu M; Hoffman RM
Anticancer Res; 2016 May; 36(5):2113-7. PubMed ID: 27127111
[TBL] [Abstract][Full Text] [Related]
23. A mouse model for developing treatment for secondary liver tumors.
Cai SR; Garbow JR; Culverhouse R; Church RD; Zhang W; Shannon WD; McLeod HL
Int J Oncol; 2005 Jul; 27(1):113-20. PubMed ID: 15942650
[TBL] [Abstract][Full Text] [Related]
24. Orthotopic implantation of human colon carcinomas into nude mice provides a valuable model for the biology and therapy of metastasis.
Fidler IJ
Cancer Metastasis Rev; 1991 Oct; 10(3):229-43. PubMed ID: 1764766
[TBL] [Abstract][Full Text] [Related]
25. Targeting Methionine Addiction Combined With Low-dose Irinotecan Arrested Colon Cancer in Contrast to High-dose Irinotecan Alone, Which Was Ineffective, in a Nude-mouse Model.
Sato M; Mizuta K; Han Q; Morinaga S; Kang BM; Kubota Y; Mori R; Baranov A; Kobayashi K; Ardjmand D; Kobayashi N; Bouvet M; Ichikawa Y; Nakajima A; Hoffman RM
In Vivo; 2024; 38(3):1058-1063. PubMed ID: 38688611
[TBL] [Abstract][Full Text] [Related]
26. In vivo selection of highly metastatic cells from surgical specimens of different primary human colon carcinomas implanted into nude mice.
Morikawa K; Walker SM; Jessup JM; Fidler IJ
Cancer Res; 1988 Apr; 48(7):1943-8. PubMed ID: 3349467
[TBL] [Abstract][Full Text] [Related]
27. Heterogeneity-related anticancer therapy response differences in metastatic colon carcinoma: new hints to tumor-site-based personalized cancer therapy.
Pan W; Huang S; Zhang J; Zhao B; Wang H; Liu F; Jin K; Mou X
Hepatogastroenterology; 2013; 60(128):1927-34. PubMed ID: 24719929
[TBL] [Abstract][Full Text] [Related]
28. Prevention of intestinal toxic effects and intensification of irinotecan's therapeutic efficacy against murine colon cancer liver metastases by oral administration of the lipopeptide JBT 3002.
Shinohara H; Killion JJ; Kuniyasu H; Kumar R; Fidler IJ
Clin Cancer Res; 1998 Sep; 4(9):2053-63. PubMed ID: 9748119
[TBL] [Abstract][Full Text] [Related]
29. Irinophore C™, a lipid nanoparticulate formulation of irinotecan, improves vascular function, increases the delivery of sequentially administered 5-FU in HT-29 tumors, and controls tumor growth in patient derived xenografts of colon cancer.
Neijzen R; Wong MQ; Gill N; Wang H; Karim T; Anantha M; Strutt D; Waterhouse D; Bally MB; Tai IT; Ng SS; Yapp DT
J Control Release; 2015 Feb; 199():72-83. PubMed ID: 25497312
[TBL] [Abstract][Full Text] [Related]
30. An ultra-metastatic model of human colon cancer in nude mice.
Sun FX; Sasson AR; Jiang P; An Z; Gamagami R; Li L; Moossa AR; Hoffman RM
Clin Exp Metastasis; 1999 Feb; 17(1):41-8. PubMed ID: 10390146
[TBL] [Abstract][Full Text] [Related]
31. Resection of hepatic metastasis after 5-fluorouracil and cofactor for colon cancer.
Costantini CL; Reid TR; Bouvet M
Hepatogastroenterology; 2009; 56(91-92):645-9. PubMed ID: 19621672
[TBL] [Abstract][Full Text] [Related]
32. Liver metastasis models of colon cancer for evaluation of drug efficacy using NOD/Shi-scid IL2Rgammanull (NOG) mice.
Hamada K; Monnai M; Kawai K; Nishime C; Kito C; Miyazaki N; Ohnishi Y; Nakamura M; Suemizu H
Int J Oncol; 2008 Jan; 32(1):153-9. PubMed ID: 18097554
[TBL] [Abstract][Full Text] [Related]
33. Marked activity of irinotecan and rapamycin combination toward colon cancer cells in vivo and in vitro is mediated through cooperative modulation of the mammalian target of rapamycin/hypoxia-inducible factor-1alpha axis.
Pencreach E; Guérin E; Nicolet C; Lelong-Rebel I; Voegeli AC; Oudet P; Larsen AK; Gaub MP; Guenot D
Clin Cancer Res; 2009 Feb; 15(4):1297-307. PubMed ID: 19190131
[TBL] [Abstract][Full Text] [Related]
34. Liver metastasis from colonic adenocarcinoma presenting as nephrolithiasis: computed tomography findings.
Abu-Ghanem S; Novik EF; Abu-Ghanem Y; Man S; Shelef I
Isr Med Assoc J; 2011 Oct; 13(10):638-9. PubMed ID: 22097237
[No Abstract] [Full Text] [Related]
35. Pharmacokinetic profile of the microtubule stabilizer patupilone in tumor-bearing rodents and comparison of anti-cancer activity with other MTS in vitro and in vivo.
O'Reilly T; Wartmann M; Brueggen J; Allegrini PR; Floersheimer A; Maira M; McSheehy PM
Cancer Chemother Pharmacol; 2008 Nov; 62(6):1045-54. PubMed ID: 18301895
[TBL] [Abstract][Full Text] [Related]
36. Crumbs3 is a critical factor that regulates invasion and metastasis of colon adenocarcinoma via the specific interaction with FGFR1.
Iioka H; Saito K; Sakaguchi M; Tachibana T; Homma K; Kondo E
Int J Cancer; 2019 Nov; 145(10):2740-2753. PubMed ID: 30980524
[TBL] [Abstract][Full Text] [Related]
37. A new animal model for human colon cancer metastasis.
Bresalier RS; Raper SE; Hujanen ES; Kim YS
Int J Cancer; 1987 May; 39(5):625-30. PubMed ID: 3032811
[TBL] [Abstract][Full Text] [Related]
38. [Suppression of the growth of subcutaneous transplanted human liver cancer and lung metastasis in nude mice treated by sorafenib combined with fluorouracil].
Shen HJ; Wang YH; Xu J
Zhonghua Zhong Liu Za Zhi; 2013 Feb; 35(2):98-102. PubMed ID: 23714662
[TBL] [Abstract][Full Text] [Related]
39. The laminin alpha 1 chain Ile-Lys-Val-Ala-Val (IKVAV)-containing peptide promotes liver colonization by human colon cancer cells.
Bresalier RS; Schwartz B; Kim YS; Duh QY; Kleinman HK; Sullam PM
Cancer Res; 1995 Jun; 55(11):2476-80. PubMed ID: 7758002
[TBL] [Abstract][Full Text] [Related]
40. A nude mouse model of massive liver and lymph node metastasis of human colon cancer.
Rashidi B; Sun FX; Jiang P; An Z; Gamagami R; Moossa AR; Hoffman RM
Anticancer Res; 2000; 20(2A):715-22. PubMed ID: 10810345
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
